Gilead Sciences

Open: 78.3 Close: 77.04 Change: -1.26

The best way to get informed about Gilead Sciences Stock without reading hundreds of pages.

How much time have you spent trying to decide whether investing in Gilead Sciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences has an advanced drug discovery and commercialisation pipeline across HIV, cancer, and inflammation, among other areas. Analyst Consensus: Buy Stock Forecasts: Buy stock.

Today's News

Gilead Sciences Inc. per Employee $1.601M P/E ratio 17.72 EPS $4.35 Yield 3.89% Dividend $0.75 Ex-Dividend date Sep 14, 2023. Gilead Sciences, Inc. (GILD) has risen 0.98% Wednesday In Premarket Trading. The company ranks higher than 67% of stocks in the Drug Manufacturers - General industry. Gilead Sciences has an advanced drug discovery and commercialisation pipeline across HIV, cancer, and inflammation, among other areas. US FDA puts Gilead Sciences blood cancer drug studies on hold. US FDA put Gileads blood cancer Drug Studies on hold Monday. Gilead Sciences to present at upcoming investor conferences. The Gileade Sciences lawsuit is In re: HIV Antitrust Litigation. FDA Halts Clinical Trial Enrollment for Gileads Magrolimab in AML Studies. Gilead Sciences and Tentarix Biotherapeutics have officially started three multi-year collaborations with the goal of discovering and developing multi-functional, conditional protein therapeutics. Gilead Sciences to Present at Upcoming Investor Conferences. Analyst Consensus: Buy Stock Forecasts: Buy stock with 18.03% upside.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

Are looking for the most relevant information about Gilead Sciences? Investor spend a lot of time searching for information to make investment decisions in Gilead Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, cancer, FDA, Inc, stock, Drug, and the most common words in the summary are: gilead, science, job, stock, market, gild, inc, . One of the sentences in the summary was: Analyst Consensus: Buy Stock Forecasts: Buy stock.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #job #stock #market #gild #inc.